Abstract
The cyanoacrylate compound phenamacril (also known as JS399-19) is a recently identified fungicide that exerts its antifungal effect on susceptible Fusarium species by inhibiting the ATPase activity of their myosin class I motor domains. Although much is known about the antifungal spectrum of phenamacril, the exact mechanism behind the phenamacril-mediated inhibition remains to be resolved. Here, we describe the characterization of the effect of phenamacril on purified myosin motor constructs from the model plant pathogen and phenamacril-susceptible species Fusarium graminearum, phenamacril-resistant Fusarium species, and the mycetozoan model organism Dictyostelium discoideum Our results show that phenamacril potently (IC 50 ∼360 nm), reversibly, and noncompetitively inhibits ATP turnover, actin binding during ATP turnover, and motor activity of F. graminearum myosin-1. Phenamacril also inhibits the ATPase activity of Fusarium avenaceum myosin-1 but has little or no inhibitory effect on the motor activity of Fusarium solani myosin-1, human myosin-1c, and D. discoideum myosin isoforms 1B, 1E, and 2. Our findings indicate that phenamacril is a species-specific, noncompetitive inhibitor of class I myosin in susceptible Fusarium sp.
Original language | English |
---|---|
Journal | Journal of Biological Chemistry |
Volume | 294 |
Issue number | 4 |
Pages (from-to) | 1328-1337 |
Number of pages | 10 |
ISSN | 0021-9258 |
DOIs | |
Publication status | Published - 25 Jan 2019 |
Bibliographical note
© 2019 Wollenberg et al.Keywords
- Fungicides, Industrial/pharmacology
- Fusarium/drug effects
- Gene Expression Regulation, Fungal/drug effects
- Myosin Type I/antagonists & inhibitors
- Protein Conformation
- Species Specificity